← GLOBUS MEDICAL INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $104.3m |
$107.3m
+2.88%
|
$156.5m
+45.76%
|
$155.2m
-0.81%
|
$102.3m
-34.10%
|
$149.2m
+45.86%
|
$190.2m
+27.47%
|
$122.9m
-35.39%
|
$103.0m
-16.19%
|
$537.9m
+422.28%
|
— | |
| Depreciation, Depletion and Amortization | $38.8m | $42.1m | $41.6m | $52.7m | $62.9m | $69.9m | $68.3m | $144.7m | $254.0m | $276.8m | $279.9m | |
| Depreciation | $35.3m | $34.2m | $32.0m | $38.9m | $46.0m | $51.3m | $50.5m | $93.7m | $134.7m | $159.3m | $279.9m | |
| Amortization of Intangible Assets | $3.5m | $7.9m | $9.6m | $13.8m | $16.8m | $18.5m | $17.7m | $51.0m | $119.4m | $118.2m | — | |
| Deferred Income Tax Expense (Benefit) | ($4.1m) | $8.2m | $971k | $4.3m | ($3.9m) | ($17.6m) | ($22.3m) | ($58.2m) | ($134.0m) | — | $75.6m | |
| Share-based Payment Arrangement, Noncash Expense | $11.4m | $14.7m | $21.9m | $26.1m | $27.1m | $30.6m | $32.8m | $52.7m | $54.2m | $49.8m | $49.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | $10.6m | $6.7m | $2.9m | — | |
| Share-based Payment Arrangement, Expense | $11.4m | $14.7m | $21.9m | $26.1m | $27.1m | $30.6m | $32.8m | $39.0m | $54.2m | $49.8m | $49.0m | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | $11.7m | $14.9m | $22.2m | $26.4m | $27.3m | $31.3m | $33.5m | $52.8m | $54.3m | $76.5m | $49.0m | |
| Goodwill and Intangible Asset Impairment | — | — | — | $0 | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $3.5m | $516k | $0 | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | ($45.3m) | $125.3m | — | |
| Other Nonoperating Income (Expense) | $3.1m | $8.1m | $19.3m | $18.0m | $14.5m | $8.5m | $15.1m | $32.3m | $2.2m | $3.4m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $4.7m | $25.0m | $21.8m | $18.3m | ($10.7m) | $25.9m | $50.8m | $49.9m | $78.1m | $52.2m | ($99.8m) | |
| Increase (Decrease) in Inventories | $10.5m | $5.3m | $31.4m | $50.0m | $50.1m | $12.0m | $61.7m | $70.3m | $29.9m | $17.6m | ($50.4m) | |
| Inventory Write-down | $12.8m | $11.5m | $10.5m | $2.5m | $17.7m | $6.1m | $6.4m | $11.0m | $23.4m | $22.1m | — | |
| Increase (Decrease) in Accounts Payable | ($23k) | $9.8m | ($3.0m) | $773k | ($6.4m) | $3.7m | $14.4m | ($14.2m) | $17.7m | $8.5m | $18.0m | |
| Net Cash Provided by (Used in) Operating Activities | $171.9m |
$159.5m
-7.19%
|
$181.6m
+13.86%
|
$172.0m
-5.32%
|
$198.8m
+15.59%
|
$276.3m
+38.98%
|
$178.5m
-35.40%
|
$243.5m
+36.44%
|
$520.6m
+113.82%
|
$753.4m
+44.72%
|
$910.4m
+20.83%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $40.9m | $51.3m | $59.7m | $70.8m | $63.7m | $56.9m | $74.0m | $78.3m | $115.4m | $164.7m | ($164.5m) | |
| Payments to Acquire Investments | $287.3m | $392.9m | $537.9m | $346.5m | $223.5m | $622.4m | $419.5m | $100.6m | $113.5m | — | ($359.8m) | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $281.9m | $240.4m | $278.0m | $247.0m | $134.5m | $227.9m | $312.2m | $240.2m | $58.7m | $63.9m | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $76.1m | $29.9m | $14.8m | $23.8m | $33.5m | $34.5m | $31.4m | $296.0m | $17.6m | $252.5m | ($1.4m) | |
| Net Cash Provided by (Used in) Investing Activities | ($99.6m) | ($111.3m) | ($193.0m) | ($140.3m) | ($117.3m) | ($375.9m) | ($110.4m) | $303.0m | ($176.1m) | ($355.0m) | ($499.0m) | |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common Stock | — | — | — | — | $104.7m | — | $144.5m | $225.6m | $85.8m | $300.5m | — | |
| Net Cash Provided by (Used in) Financing Activities | $2.0m |
$1.6m
-20.33%
|
$32.6m
+1903.08%
|
$24.4m
-24.96%
|
($38.7m)
-258.20%
|
$54.1m
+240.05%
|
($110.0m)
-303.08%
|
($231.8m)
-110.82%
|
($27.7m)
+88.05%
|
($679.2m)
-2352.20%
|
($135.1m)
+80.10%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $20.9m | ($156k) | $43.7m | ($46.3m) | ($42.6m) | $316.8m | $317.1m | ($258.3m) | $505.7m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $139.7m | $195.7m | $239.4m | $193.1m | $150.5m | $467.3m | $784.4m | $526.2m | $505.7m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($256k) | ($156k) | $865k | ($810k) | ($747k) | $2.2m | $255k | $22.4m | $2.1m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $5.9m | $11.7m | $39.3m | $31.0m | $72.3m | $63.5m | $41.7m | $12.4m | $110.4m | $89.8m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, Net | $50.1m | $59.1m | $30.6m | $34.1m | $25.4m | $45.0m | $77.8m | $100.6m | $158.5m | $98.9m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($482k) | $909k | $360k | $75k | ($279k) | ($1.4m) | ($1.0m) | $14.3m | ($43.3m) | ($3.0m) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | — | — | — | — | — | $14.1m | ($43.3m) | ($3.0m) | — | |
| Gain (Loss) on Disposition of Assets | — | — | $3.6m | ($866k) | ($809k) | ($464k) | ($299k) | ($1.5m) | ($5.6m) | ($12.5m) | — | |
| Goodwill | $105.9m | $123.9m | $123.7m | $128.8m | $156.7m | $179.7m | $197.5m | $1.4b | $1.4b | $1.4b | — | |
| Income Tax Expense (Benefit) | $52.9m | $62.6m | $32.1m | $34.7m | $23.6m | $31.2m | $52.9m | $42.5m | $17.7m | $67.2m | — | |
| Operating Expenses | $275.1m | $323.7m | $384.2m | $433.4m | $460.1m | $546.9m | $531.2m | $887.2m | — | — | — | |
| Operating Lease, Expense | — | — | — | $3.2m | $3.6m | $3.4m | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | — | — | $23.8m | $15.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.